Potential role of sphingosine 1-phosphate in the pathogenesis of rheumatoid arthritis

Research output: Contribution to journalComment/debate

3 Citations (Scopus)

Abstract

In summary, S1P functions through multiple receptors, of which three are expressed in fibroblast-like synoviocytes, a cell type that appears to malfunction in rheumatoid arthritis. Bourgoin and colleagues demonstrated the role of these receptors in synoviocyte migration, survival, and inflammatory cytokine production, processes that are involved in the pathophysiology of rheumatoid arthritis. Furthermore, these authors showed that pretreatment of fibroblast-like synoviocytes with TNFa increases expression of the S1P3 receptor and enhances inflammatory cytokine/chemokine production in response to this agent, an effect that probably serves to exacerbate the disease process. Thus, the results reported here suggest the possibility of using S1P receptor antagonists and/or inhibitors of sphingosine kinase, either alone or in combination with drugs that target the TNFa pathway, for the treatment of rheumatoid arthritis.

Original languageEnglish (US)
Pages (from-to)2281-2282
Number of pages2
JournalJournal of Lipid Research
Volume49
Issue number11
DOIs
StatePublished - Dec 1 2008

Fingerprint

Lysosphingolipid Receptors
Fibroblasts
Rheumatoid Arthritis
Cytokines
Chemokines
Drug Combinations
Pharmaceutical Preparations
sphingosine 1-phosphate
Synoviocytes
sphingosine kinase

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Potential role of sphingosine 1-phosphate in the pathogenesis of rheumatoid arthritis. / Bollag, Wendy B.

In: Journal of Lipid Research, Vol. 49, No. 11, 01.12.2008, p. 2281-2282.

Research output: Contribution to journalComment/debate

@article{dd432a6ae6e74545b53b554809b9d1fd,
title = "Potential role of sphingosine 1-phosphate in the pathogenesis of rheumatoid arthritis",
abstract = "In summary, S1P functions through multiple receptors, of which three are expressed in fibroblast-like synoviocytes, a cell type that appears to malfunction in rheumatoid arthritis. Bourgoin and colleagues demonstrated the role of these receptors in synoviocyte migration, survival, and inflammatory cytokine production, processes that are involved in the pathophysiology of rheumatoid arthritis. Furthermore, these authors showed that pretreatment of fibroblast-like synoviocytes with TNFa increases expression of the S1P3 receptor and enhances inflammatory cytokine/chemokine production in response to this agent, an effect that probably serves to exacerbate the disease process. Thus, the results reported here suggest the possibility of using S1P receptor antagonists and/or inhibitors of sphingosine kinase, either alone or in combination with drugs that target the TNFa pathway, for the treatment of rheumatoid arthritis.",
author = "Bollag, {Wendy B}",
year = "2008",
month = "12",
day = "1",
doi = "10.1194/jlr.E800016-JLR200",
language = "English (US)",
volume = "49",
pages = "2281--2282",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Potential role of sphingosine 1-phosphate in the pathogenesis of rheumatoid arthritis

AU - Bollag, Wendy B

PY - 2008/12/1

Y1 - 2008/12/1

N2 - In summary, S1P functions through multiple receptors, of which three are expressed in fibroblast-like synoviocytes, a cell type that appears to malfunction in rheumatoid arthritis. Bourgoin and colleagues demonstrated the role of these receptors in synoviocyte migration, survival, and inflammatory cytokine production, processes that are involved in the pathophysiology of rheumatoid arthritis. Furthermore, these authors showed that pretreatment of fibroblast-like synoviocytes with TNFa increases expression of the S1P3 receptor and enhances inflammatory cytokine/chemokine production in response to this agent, an effect that probably serves to exacerbate the disease process. Thus, the results reported here suggest the possibility of using S1P receptor antagonists and/or inhibitors of sphingosine kinase, either alone or in combination with drugs that target the TNFa pathway, for the treatment of rheumatoid arthritis.

AB - In summary, S1P functions through multiple receptors, of which three are expressed in fibroblast-like synoviocytes, a cell type that appears to malfunction in rheumatoid arthritis. Bourgoin and colleagues demonstrated the role of these receptors in synoviocyte migration, survival, and inflammatory cytokine production, processes that are involved in the pathophysiology of rheumatoid arthritis. Furthermore, these authors showed that pretreatment of fibroblast-like synoviocytes with TNFa increases expression of the S1P3 receptor and enhances inflammatory cytokine/chemokine production in response to this agent, an effect that probably serves to exacerbate the disease process. Thus, the results reported here suggest the possibility of using S1P receptor antagonists and/or inhibitors of sphingosine kinase, either alone or in combination with drugs that target the TNFa pathway, for the treatment of rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=58149465058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149465058&partnerID=8YFLogxK

U2 - 10.1194/jlr.E800016-JLR200

DO - 10.1194/jlr.E800016-JLR200

M3 - Comment/debate

VL - 49

SP - 2281

EP - 2282

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 11

ER -